angiotensin ii has been researched along with ticagrelor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, X; Han, Y; Li, M; Li, Y; Wang, X; Zhang, Y; Zhao, S | 1 |
| Abo-Saif, AA; El-Sayed El-Daly, M; Moustafa Ahmed, Y; Shehata Messiha, BA | 1 |
2 other study(ies) available for angiotensin ii and ticagrelor
| Article | Year |
|---|---|
Ticagrelor protects against AngII-induced endothelial dysfunction by alleviating endoplasmic reticulum stress.
Topics: Angiotensin II; Animals; Biomarkers; Cells, Cultured; Endoplasmic Reticulum Stress; Endothelial Cells; Endothelium, Vascular; Male; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Ticagrelor; Vasodilation | 2018 |
Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.
Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Aorta; Arthritis, Rheumatoid; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Glucosides; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinases; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WF; Receptors, Purinergic P2Y12; Selective Estrogen Receptor Modulators; Sodium-Glucose Transporter 2 Inhibitors; Tamoxifen; Ticagrelor; Vascular Cell Adhesion Molecule-1; Vasodilation | 2019 |